Last updated: 2026-09-16 06:00:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
GE HealthCare Technologies Inc. (GEHC) operates in the X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $64.07, with a market capitalisation of $28.88B and a P/E ratio of 14.62. Over the past 52 weeks, its price has ranged from $58.75 to $89.77. This page covers its latest market performance, valuation, price trends and company information.
$28.88B | |
$64.25 | |
$94.80 | |
$53.50 | |
$64.25 | |
3.57M | |
4.37M | |
14.62 | |
$89.77 | |
$58.75 | |
0.22% | |
-- |
GE HealthCare Technologies Inc. (GEHC) last closed at $64.25 as of 2026-09-15 23:59:00, unchanged from the previous close of $64.25.
During the latest regular trading session, GEHC traded between $53.50 and $94.80, with a volume of 3.57M shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, GE HealthCare Technologies Inc. (GEHC) moved from $69.72 to $64.07, representing a decline of 8.10% ($5.65).
The stock traded between $63.22 and $71.36 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 3.12 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 17.2%
GEHC is currently trading at $64.07, placing it 17.2% of the way from its 52-week low of $58.75 to its 52-week high of $89.77. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
| Industry | X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS |
| Employees | 54000 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of GE HealthCare Technologies Inc. (GEHC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.